Subham Basu Email and Phone Number
Subham Basu work email
- Valid
- Valid
- Valid
- Valid
Subham Basu personal email
Currently working as Chief Business Officer in the life science and diagnostics industry, I have recently served as a consultant to the pharmaceutical and diagnostic industries as well as to venture capital funds. I have extensive prior experience in medical affairs and market access in pharma and have also led a competitive research laboratory in academia and therefore have hands-on expertise from pre-clinical work to marketing in the biomedical industry.Key Experience:• Leading global sales, marketing and business development teams in diagnostics and life sciences• Developed and directed commercial strategy for life sciences and biotechnology• Work with business development and corporate development on partnerships and licensing• Global medical lead for diagnostics strategy for oncology drug across tumors and indications• Developed Medical and Market Access strategy for launch of novel oncology assets in both solid cancer and hematology oncology in UK and Europe• Represented company at NICE and SMC HTA hearings• Consulting for scientific/clinical due diligence and market competitor intelligence• Key Opinion Leader (KOL) development and management• Directed independent oncology research laboratory at leading academic cancer center• Effective communicator, writer, and meeting/conference organizer
-
Chief Business OfficerNavinci Diagnostics Apr 2023 - PresentUppsala, Uppsala County, SeLeading sales, marketing, business development and strategy for innovative spatial biology company.
-
Senior Director Of Commercial Strategy, Immuno-Oncology And OncologyAbcam Jul 2021 - Apr 2023Cambridge, Cambridgeshire, Gb• Continuing to lead on Immuno-oncology and Oncology strategy with greater focus on external engagement via corporate and business development• Direct launch of individual and classes of assets for Immuno-oncology and Oncology• Establish and develop Oncology Research Area, developing in-house talent and building out portfolio and directing commercial strategy• Scouting and leading on partnering with pharma, biotechnology, and academic research centers, working with business development and corporate development teams to expand company portfolio and ensure Abcam assets have maximum exposure in market -
Director Of Strategy, Immuno-OncologyAbcam Jul 2019 - Jul 2021Cambridge, Cambridgeshire, GbDevelop and direct commercial strategy for immuno-oncology portfolio for Abcam, working cross-functionally with marketing, sales, product development and validation, research and business development teams. Vision is to ensure that all researchers ( working across fundamental research, drug discovery, translational medicine and clinical science and across academia, biotech/ pharma and diagnostics/platforms) can access the best tools and solutions for their immuno-oncology advancements for identifying, selecting and treating patients for optimal care.
-
Head Of StrategyInflection Point Biomedical Advisors Jun 2018 - Jul 2019I am a clinical and biomedical sciences expert, with an oncology and platform technology focus. Prior to joining IPBA, I served as Global Medical Affairs Diagnostics Lead for AZ’s DNA Damage franchise, working with commercial, medical, clinical and pre-clinical teams, and in collaboration with Merck to lead Dx strategies in ovarian, breast, prostate and pancreatic cancers. I have over 7 years experience working with UK, European and Global teams in oncology with Shire/Baxlata, Otsuka/BMS and Genzyme in implementing brand strategies for pre-marketed and just-launched marketed assets in oncology and hematology. I have also worked deeply within market access/HEOR and has been UK lead on HTA presentations to NICE. I conduct due diligence and scouting for leads for pharma venture capital and BD. Previous to industry, I have prior experience in directing a competitive research laboratory in academia and therefore have hands-on leadership in pre-clinical work to marketing of drugs.
-
AdvisorArticle25 Capital Jun 2018 - Jul 2019Clinical and biomedical sciences expert, with an oncology and platform technology focus, currently working in strategy consulting and venture capital+8 years in pharmaceutical industry in diagnostics, medical affairsExtensive prior experience in leading a competitive research laboratory in academiaPhD, Molecular Pharmacology, Cornell University/Memorial Sloan Kettering Cancer Center -
Global Medical Affairs Leader, Lynparza And Dna Damage Repair (Ddr) Pathway FranchiseAstrazeneca Sep 2017 - May 2018Cambridge, Cambridgeshire, Gb -
Head Medical Affairs Oncology, United Kingdom And Republic Of IrelandShire Jun 2016 - Sep 2017Tokyo, Jp, Jp• Led scientific/clinical due diligence for go/no-go decisions to expand Baxter/Baxalta Venture Capital portfolio as well as scouting for new leads in US and Europe which were actively pursued • Consulting on Business Development leads.• Cross-functional engagement with Medical, Market Access, Health Economy Outcomes Research (HEOR), Clinical Development and Marketing teams across Europe and Globally to launch Oncaspar (pegylated aspariginase) in acute lymphoblastic leukaemia (ALL) and Onivyde (liposomal irinotecan) in pancreatic cancer as first oncology assets developed by Baxalta/Shire in UK and Europe.• Successfully obtained positive National Institute of Clinical and Care Excellence (NICE) and Scottish Medical Council (SMC) Health Technology Assessment (HTA) approvals in UK for Oncaspar in ALL.• Led Global projects to generate educational and promotional materials for training, congress programmes and speaker development.• Directed Medical Affairs, Market Access, HEOR and Marketing Advisory Boards in UK and Europe.• Developed and implemented medical plan and budget for oncology assets in UK and Ireland.• Experience with directing various agencies for external help in generating materials, developing HTA dossiers, coordinating advisory boards and educational programmes -
Head Medical Affairs Oncology, United Kingdom And Republic Of IrelandBaxalta Jun 2015 - Jun 2016Illinois, UsI am the country-wide lead for medical and clinical strategy for oncology products and services, including pre-launch planning, trial support and KOL development. I work across departments, including Market Access, Patient Access, Marketing and with Global and European colleagues to help generate and deliver the oncology medical affairs plan for UK and Ireland. -
Medical Advisor Oncology, Uk And Republic Of IrelandBaxalta May 2015 - Jun 2015Illinois, UsMedical and clinical strategy for oncology products and services, including pre-launch planning, trial support and KOL development. I work across departments, including Market Access, Patient Access, Marketing and with Global and European colleagues to help generate and deliver the oncology medical affairs plan for UK and Ireland.
-
Medical Advisor, OncologyBaxter International Inc. Feb 2014 - May 2015Deerfield, Illinois, UsMedical and clinical strategy for investigational and licensed oncology products and services, including pre-launch and trial planning and support and KOL development. -
Medical Sciences Manager, OncologyOtsuka Pharmaceuticals (Uk) Ltd, Uxbridge Nov 2011 - Feb 2014Medical support for marketed products and investigational products, including:Key Opinion Leader development and management.Presenting clinical data and participation in advisory meetings.Clinical development support (investigator supported studies, etc)Medical and strategy planning.
-
Clinical Research AdvisorGenzyme Apr 2011 - Nov 2011Contracted to advise and assist on clinical research, focusing on investigator supported studies.
-
Senior LecturerBarts And The London School Of Medicine, Qmul 2004 - Oct 2010• Strong publication record in high impact journals including demonstrating regulation of key signaling molecules in cancer.• Successfully supervised 5 postdoctoral fellows and 3 PhD students, who have gone to top-flight academic postdoctoral fellowships in world class institutions such as MIT as well as Senior Project Executive posts in leading medical publishing firms.• Secured competitive grant money equivalent to over $1.5 million from Cancer Research UK and Barts and the London Trust charities.• Effective communicator and writer, with published reviews in high profile journal such as Molecular Cell, Cell Death and Differentiation, Oncogene and Cell Cycle. Presented invited seminars at international conferences and leading research institutes and universities.
-
Group LeaderCancer Research Uk 2003 - Oct 2010London, Gb• Discovered detailed mechanisms of tumorigenesis and chemoresistance for druggable targets including Raf, Akt, JNK, Abl kinases and p53 family members and others using a range of cutting edge in vitro techniques including functional proteomic screens and in vivo assays in cell culture and mice.• Designed, developed and characterized new, innovative reagents such as phospho-specific antibodies, cells lines stably expressing mutant constructs and advised on transgenic animals. -
Postdoctoral FellowCancer Research Uk 1999 - 2003London, GbWorked in Signal Transduction Laboratory in identifying and characterizing substrates of Akt involved in tumorigenesis.
-
LecturerHammersmith Hospital, Faculty Of Medicine, Imperial College London 2003 2003 - 2004Established Cell Survival Signalling Laboratory in CRUK Molecular Oncology Unit.
-
Phd StudentMemorial Sloan-Kettering Cancer Center 1993 - 1999New York, Ny, Us• Characterized the effect of the bioactive lipid ceramide in signaling apoptosis through activation of Ras and Raf-1 and inactivation of Ak
Subham Basu Skills
Subham Basu Education Details
-
Imperial College Business SchoolMergers & Acquisitions Program -
Cornell UniversityMolecular Pharmacology
-
University Of California, BerkeleyNeuroscience Field Major
-
Stuyvesant High School
Frequently Asked Questions about Subham Basu
What company does Subham Basu work for?
Subham Basu works for Navinci Diagnostics
What is Subham Basu's role at the current company?
Subham Basu's current role is Chief Business Officer, Navinci Diagnostics.
What is Subham Basu's email address?
Subham Basu's email address is su****@****o.co.uk
What schools did Subham Basu attend?
Subham Basu attended Imperial College Business School, Cornell University, University Of California, Berkeley, Stuyvesant High School.
What skills is Subham Basu known for?
Subham Basu has skills like Cell Biology, Oncology, Biochemistry, In Vitro, Cancer, Clinical Development, Cell, Cancer Research, Proteomics, In Vivo, Clinical Trials, Assay Development.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial